Table 3 Microbiological profile on survivors and non-survivors
|  | All patients (n = 219) | Survivors (n = 156) | Non-survivors (n = 63) | P-value |
|---|---|---|---|---|
Identified pathogens, n (%) | 157 (71.1) | 117 (75.0) | 40 (63.5) | 0.087 |
Bacteremia, n (%) | 108 (49.3) | 76 (48.7) | 32 (50.8) | 0.781 |
Type of bacteria, n (%) | Â | Â | Â | Â |
 Gram-positive | 51 (32.5) | 34 (29.1) | 17 (42.5) | 0.112 |
 Gram-negative | 128 (81.5) | 95 (81.2) | 33 (82.5) | 0.322 |
Fungus, n (%) | 7 (4.5) | 6 (5.1) | 1 (2.5) | 0.390 |
Mixed growth, n (%) | 30 (19.1) | 19 (16.2) | 11 (27.5) | 0.304 |
MDR, n (%) | 72 (45.9) | 56 (47.9) | 16 (40.0) | 0.134 |
 Enterobacteriaceae | 39 (54.2) | 30 (53.6) | 9 (56.3) | 0.387 |
 Enterococcus spp. | 9 (12.5) | 5 (8.9) | 4 (25.0) | 0.289 |
 Acinetobacter spp. | 3 (4.2) | 2 (3.6) | 1 (6.3) | 0.860 |
 Staphylococcus aureus | 2 (2.8) | 1 (1.8) | 1 (6.3) | 0.505 |
 Pseudomonas aeruginosa | 2 (2.8) | 2 (3.6) | 0 | 0.367 |
 Others | 21 (29.2) | 18 (32.1) | 3 (18.8) | 0.123 |
Location of infection, n (%) | Â | Â | Â | Â |
 Community-acquired | 135 (61.6) | 96 (61.5) | 39 (61.9) | 0.960 |
 Healthcare-acquired | 84 (38.4) | 60 (38.5) | 24 (38.1) | 0.960 |